High-throughput functional assay in cystic fibrosis patient-derived organoids allows drug repurposing
出版年份 2022 全文链接
标题
High-throughput functional assay in cystic fibrosis patient-derived organoids allows drug repurposing
作者
关键词
-
出版物
ERJ Open Research
Volume 9, Issue 1, Pages 00495-2022
出版商
European Respiratory Society (ERS)
发表日期
2022-12-22
DOI
10.1183/23120541.00495-2022
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Forskolin-induced Organoid Swelling is Associated with Long-term CF Disease Progression
- (2022) Danya Muilwijk et al. EUROPEAN RESPIRATORY JOURNAL
- Targeting G542X CFTR nonsense alleles with ELX-02 restores CFTR function in human-derived intestinal organoids
- (2021) Daniel K. Crawford et al. Journal of Cystic Fibrosis
- Discovery of CFTR modulators for the treatment of cystic fibrosis
- (2021) Miquéias Lopes-Pacheco et al. Expert Opinion on Drug Discovery
- Functional Restoration of CFTR Nonsense Mutations in Intestinal Organoids
- (2021) E. de Poel et al. Journal of Cystic Fibrosis
- A role for AKT1 in nonsense-mediated mRNA decay
- (2021) Martine Palma et al. NUCLEIC ACIDS RESEARCH
- A new platform for high-throughput therapy testing on iPSC-derived lung progenitor cells from cystic fibrosis patients
- (2021) Jia Xin Jiang et al. Stem Cell Reports
- PHD1 controls muscle mTORC1 in a hydroxylation-independent manner by stabilizing leucyl tRNA synthetase
- (2020) Gommaar D’Hulst et al. Nature Communications
- Rectal Organoids Enable Personalized Treatment of Cystic Fibrosis
- (2019) Gitte Berkers et al. Cell Reports
- High-Throughput Surface Liquid Absorption and Secretion Assays to Identify F508del CFTR Correctors Using Patient Primary Airway Epithelial Cultures
- (2019) Allison Berg et al. SLAS Discovery
- Cholesterol Interaction Directly Enhances Intrinsic Activity of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)
- (2019) Chin et al. Cells
- Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial
- (2019) Harry G M Heijerman et al. LANCET
- A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity
- (2018) Norman Sachs et al. CELL
- Intestinal Failure and Aberrant Lipid Metabolism in Patients With DGAT1 Deficiency
- (2018) Jorik M. van Rijn et al. GASTROENTEROLOGY
- Stratifying infants with cystic fibrosis for disease severity using intestinal organoid swelling as a biomarker of CFTR function
- (2018) Karin M. de Winter-de Groot et al. EUROPEAN RESPIRATORY JOURNAL
- In situ click chemistry generation of cyclooxygenase-2 inhibitors
- (2017) Atul Bhardwaj et al. Nature Communications
- Characterizing responses to CFTR-modulating drugs using rectal organoids derived from subjects with cystic fibrosis
- (2016) Johanna F. Dekkers et al. Science Translational Medicine
- The AKT/mTOR signaling pathway plays a key role in statin-induced myotoxicity
- (2015) Annalisa Bonifacio et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Different effects of statins on induction of diabetes mellitus: an experimental study
- (2015) Shui-Ping Zhao et al. Drug Design Development and Therapy
- Cystic fibrosis: An inherited disease affecting mucin-producing organs
- (2014) Camille Ehre et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Ex vivo culture of intestinal crypt organoids as a model system for assessing cell death induction in intestinal epithelial cells and enteropathy
- (2014) T Grabinger et al. Cell Death & Disease
- Ataluren for the treatment of nonsense-mutation cystic fibrosis: a randomised, double-blind, placebo-controlled phase 3 trial
- (2014) Eitan Kerem et al. Lancet Respiratory Medicine
- Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene
- (2013) Patrick R Sosnay et al. NATURE GENETICS
- A functional CFTR assay using primary cystic fibrosis intestinal organoids
- (2013) Johanna F Dekkers et al. NATURE MEDICINE
- Identification of Synergistic Combinations of F508del Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators
- (2010) Stephen Lin et al. ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES
- Development of Novel Aminoglycoside (NB54) with Reduced Toxicity and Enhanced Suppression of Disease-Causing Premature Stop Mutations
- (2009) Igor Nudelman et al. JOURNAL OF MEDICINAL CHEMISTRY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started